ARID1A and neoplasm: The proinflammatory cytokine interleukin 6 (IL-6) was overexpressed in OCCC with concurrent ARID1A deletion and PIK3CA mutation (Figure 7), and the cytokine promoted tumour cell growth and survival [53].